0001209191-15-054837.txt : 20150618 0001209191-15-054837.hdr.sgml : 20150618 20150618200041 ACCESSION NUMBER: 0001209191-15-054837 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150617 FILED AS OF DATE: 20150618 DATE AS OF CHANGE: 20150618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001114220 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134087132 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 750 LEXINGTON AVENUE STREET 2: . CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-531-5965 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FECZKO JOSEPH M CENTRAL INDEX KEY: 0001319874 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30929 FILM NUMBER: 15941198 MAIL ADDRESS: STREET 1: PFIZER INC ATTN CORPORATE SECRETARY STREET 2: 235 EAST 42ND STREET CITY: NEW YORK STATE: NY ZIP: 10017 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-06-17 0 0001114220 KERYX BIOPHARMACEUTICALS INC KERX 0001319874 FECZKO JOSEPH M C/O KERYX BIOPHARMACEUTICALS, INC. 750 LEXINGTON AVENUE NEW YORK NY 10022 1 0 0 0 Common Stock 2015-06-17 4 A 0 10000 0.00 A 120000 D Stock Option (right to buy) 9.95 2015-06-17 4 A 0 30000 0.00 A 2016-06-17 2025-06-17 Common Stock 30000 30000 D The 10,000 shares are restricted common stock, with one-third of the 10,000 shares vesting on each of June 17, 2016, June 17, 2017 and June 17, 2018. Includes 35,000 shares of restricted stock. The 30,000 stock options vest as to one-third on each of June 17, 2016, June 17, 2017 and June 17, 2018. /s/ James F. Oliviero, III, Attorney-in-Fact 2015-06-18